Globe Life Inc.

Globe Life Inc. Earnings Recaps

GL Financials 4 recaps
Next earnings: October 28, 2026 (estimated) · full calendar
Q2 2026 Jul 25, 2026

Shares dropped 5.7% following the quarter as investors reacted negatively to decelerating life sales, particularly in key segments, and a cautious outlook on digital direct-to-consumer growth amid changing consumer behaviors. Despite margin resilience and premium growth, concerns over agent headcount declines and sales softness weighed heavily.

Key takeaways
  • Net income rose 20% year-over-year to $288 million ($3.65/share), with net operating income up 10% to $285 million ($3.61/share).
  • Life premium revenue increased 3% to $861 million; however, net life sales fell 2% at American Income Life and 15% at the direct-to-consumer (DTC) segment.
  • Agent count declined 7% year-over-year at American Income Life but showed a modest 3% sequential increase; Liberty National and Family Heritage saw agent count growth of 8% and 7%, respectively.
  • Health premium revenue grew 16% to $437 million, though health underwriting margin as a percentage of premium declined from 26% to 23%.
  • DTC sales weakness attributed to consumer shifts in online behavior and AI’s impact on paid search volume, with management noting ongoing adaptations but uncertain timing of recovery.
Q1 2026 Apr 23, 2026

Globe Life posted solid first-quarter earnings with net income of $271 million, driven by 6% premium revenue growth and strong insurance margins amid a resilient business model.

Key takeaways
  • Net operating income increased 12% year-over-year to $274 million, reflecting sustained profitability and operational efficiency.
  • Premium revenue grew 6% overall, with health premiums rising 13% and life premiums up 3%, supporting steady top-line expansion.
  • Insurance margins remained stable or improved, with life underwriting margin at 41%, and health underwriting margin at approximately 23%, aligning with full-year outlooks.
  • Agent productivity and overall sales momentum are positive, though agent count experienced slight short-term declines; strategic compensation adjustments aim to bolster future recruiting.
  • Return on equity stands at 17.9% on GAAP basis, and book value per share increased to $77.3 (GAAP) and $98.56 excluding AOCI, highlighting solid capital position.
Q3 2025 Oct 25, 2025

Globe Life Inc. delivered impressive third-quarter results with net income rising 28% year-over-year to $388 million, driven by robust growth in both life and health insurance premium revenues.

Key takeaways
  • Net operating income increased by 38% to $394 million, reflecting strong underwriting margins across life and health segments.
  • Total premium revenue grew 5% year-over-year, with life and health premiums up 3% and 9%, respectively.
  • Return on equity stands at 21.9% and book value per share increased by 12% to $93.63, demonstrating strong financial health.
  • The exclusive agency force, now over 17,500 agents, remains a key driver of long-term growth, with initiatives in place to enhance recruitment and productivity.
  • Guidance for full-year premium revenue growth remains stable at approximately 5%, consistent with the company's historical average.
Q2 2025 Jul 25, 2025

Globe Life Inc. reported second-quarter earnings with net income of $253 million, showing a slight decrease year-over-year despite a 10% increase in net operating income. Continued premium growth across life and health insurance segments indicates a robust outlook for the remainder of the year.

Key takeaways
  • Net operating income rose 10% to $271 million, reflecting strong premium revenue growth in life insurance.
  • Life premium revenue grew 3% to $840 million, while health premium revenue increased by 8% to $378 million.
  • Return on equity stands at 18.8%, with book value per share reaching $66.07, a 10% increase compared to last year.
  • Average agent count increased by 6%, signaling strong recruitment and onboarding efforts that may enhance future sales growth.
  • Administrative expenses increased by 5% but are projected to remain lower as a percentage of premium than previously estimated.